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Abstract
Background: Surgery can generate significant stress and anxiety in up to 70% of the paediatric population. There
are several pharmacological and non-pharmacological strategies to reduce pre-operative anxiety in children,
however, they have several side effects and the available information about them is contradictory. The role of
clowns and hydroxyzine in the management of anxiety is controversial, with some studies supporting and others
contraindicating both strategies.
Methods: We propose a randomised double-blind, controlled clinical trial that will evaluate the effectiveness of both
interventions (hydroxyzine and clowns), alone or in combination, to reduce pre-operative anxiety (using the modified
Yale scale of preoperative anxiety) in children aged 2–16 years undergoing outpatient surgery (n = 188).
Subjects will be randomised into two groups – (1) standard procedure (parental accompaniment) combined with
placebo or (2) standard procedure combined with preoperative hydroxyzine. After randomisation, they will be divided
by chance into two further groups, depending on the presence of clowns on the patient’s surgery day. Control of pre-
operative anxiety will be determined in the four groups by a modified Yale scale of preoperative anxiety and cortisol
levels. Compliance of children during induction of anaesthesia, time until anaesthesia recovery, presence of postoperative
delirium and use of analgesia until discharge will be also assessed. For additional information, the children, parents and
healthcare professionals involved in the study will complete a satisfaction survey.
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Conclusions: This study aims to gather evidence on which of these four therapeutic options achieves the highest
reduction of pre-operative anxiety with the best safety profile to allow paediatricians and anaesthesiologists to use the
most effective and safe option for their patients.
Trial registration: ClinicalTrials.gov identifier: NCT03324828. Registered 21 September 2017.
Keywords: Anxiety, Surgery, Clown, Hydroxyzine, Randomised clinical trial
Background
Surgery can generate significant stress and anxiety in up
to 70% of the paediatric population [1]. The need to have
specific programmes to reduce the anxiety of children is
of special interest if we consider the adverse effects of sur-
gery associated with high preoperative anxiety (POA) [2].
High levels of POA are responsible for increased surgical
morbidity [3], postoperative analgesia needs [4], and in-
creased number of days of hospitalisation and rate of com-
plications [1]. The management of POA in paediatric
patients is a field under constant review, with the studies
published to date having differing, controversial and non-
conclusive results [5, 6].
In order to reduce POA, strategic programmes that
try to minimise the emotional impact have been de-
signed. Some of these strategies are parental accom-
paniment during induction of anaesthesia [5, 6],
sedative premedication [7] and distraction techniques
[8, 9], including the presence of clowns [10] or music
therapy [11].
Pharmacological studies performed with preoperative
anxiolytic medication assess off-label drugs (such as
clonidine) or drugs that require close monitoring and
control measures (as midazolam) due to associated ser-
ious adverse events like delirium and respiratory de-
pression [12, 13]. Hydroxyzine is an antihistamine with
sedative properties approved for anxiolytic use both in
Europe and the USA. Despite its widespread use in
clinical practice, only few studies have assessed hy-
droxyzine’s effectiveness, most of which have been in
the context of minor odontology interventions [14–16].
Furthermore, there are no clinical trials about its use
for the management of POA in major outpatient paedi-
atric surgery.
Studies related to non-pharmacological techniques for
POA management have been published [5, 6, 8–11, 17]
but results related to effectiveness of accompaniment and
distraction are not confluents either [9, 17].
Humour and laughter have characteristics that
could help reduce pain and stress but the information
available is controversial; they seem to reduce anxiety
in the area of hospitalisation prior to the operation
room, but it has not yet been possible to demonstrate
their benefit as anxiolytic therapy within the surgical
area [18]. In a study by Vagnoli et al., 40 children
aged between 5 and 12 years undergoing paediatric
ambulatory surgery were randomised either to distrac-
tion and accompaniment by clowns and parents (ex-
perimental group) or to parental accompaniment only
(control group). The experimental group showed sig-
nificantly less anxiety during the induction of anaes-
thesia than the control group. According to a
healthcare professional survey, professionals consider
that clowns are beneficial for the children, however,
most of the professionals believe that the presence of
clowns adversely affects their work and would rather
not to continue with this strategy [19]. In a subse-
quent study, Vagnoli et al. concluded that the com-
bination of clowns and parental accompaniment
during the preoperative stage achieved a higher re-
duction of POA than either parental accompaniment
only or oral premedication with midazolam [20].
To summarise, the role of clowns and hydroxyzine in
the management of anxiety remains unknown, with
studies both positive for or against it. The present study
aims to address this controversy.
The main objective of this clinical trial is to show
whether the combination of hydroxyzine and distracting
techniques with clowns have an additive effect for the
control of POA. This objective will be evaluated by a
specific validated scale (modified Yale Preoperative
Anxiety Scale; m-YPAS) and determination of cortisol
levels. In addition, the satisfaction of patients, parents
and healthcare professionals with the strategy will be
evaluated by a satisfaction survey.
Methods/design
The study was approved by the appropriate Institutional
Review Board and written informed consent was obtained
from all subjects, legal surrogates, parents or legal guardians
for minor subjects.
The trial was registered prior to patient enrolment
at ClinicalTrials.gov identifier: NCT03324828 (Princi-
pal investigator: Esther Aleo Luján, Date of registra-
tion: October 30, 2017).
Trial design
This is a unicentric, randomised, controlled clinical
trial with parallel groups double blinded for
pharmacological intervention. The CONSORT
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guidelines for randomised controlled trials will be
used. This protocol also adheres to the SPIRIT
guidelines. The study schedule of enrolment, inter-
ventions and assessments are included in Fig. 1.
Population and setting
The study will be carried out in the Hospital Clínico San
Carlos (HCSC), Madrid, Spain. Patients who will undergo
paediatric ambulatory surgery will be included.
Fig. 1 Example template of recommended content for the schedule of enrolment, interventions and assessments. M0 (Moment 0):
baseline status upon arrival at the presurgical hospitalisation area; M1 (Moment 1): stay in the pre-surgical hospitalisation area; M2
(Moment 2): moment when the patient is transferred to the operating room up to the entrance to the surgical ward and parental
separation; M3 (Moment 3): time during the induction of anaesthesia in the operating room; PACU (Post-Anaesthetic Resuscitation Unit):
upon arrival at PACU and until recovery from anaesthesia. ICC Induction Compliance Checklist; m-YPAS modified Yale
Preoperative Anxiety Scale
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Inclusion criteria
The inclusion criteria will be the following:
1) Children aged between 2 and 16 years old.
2) American Society of Anesthesiologists physical
status classification grades I and II.
3) Informed consent (IC) signed by parents or legal
guardians of the minors.
4) Specific informed consent for children aged
between 12 and 16 years old.
5) No confirmed allergies to antihistamines.
Exclusion criteria
The exclusion criteria will be the following:
1) Patients who had undergone previous surgery at age
2 years or older; when children undergo operations
at an age younger than 2 years old, they do not
remember the surgical experience and therefore the
variables analysed are not influenced by this
previous experience.
2) Patients with hypersensitivity to the active
substance, to any of the excipients, to cetirizine, to
other derivatives of piperazine, to aminophylline or
to ethyleneamine.
3) Patients with porphyria.
4) Patients with diagnosed a prolongation of the QT
interval.
5) Patients with risk factors for QT interval
prolongation, including pre-existing cardiovascular
disease, electrolyte balance disturbances
(hypokalaemia, hypomagnesaemia), family history
of sudden cardiac death, significant bradycardia
and concomitant use of drugs with the potential
to produce prolongation of the QT interval and/
or induce Torsade de Pointes.
Randomisation
Following signature of the IC by the legal guardians of
the minors and/or the child’s agreement (if applicable),
randomisation to treatment with/without hydroxyzine
will be performed. Randomisation will occur in a 1:1 ra-
tio in blocks of 8. The non-blinded nurse will randomise
subjects with electronic case record form (REDCap).
The sequence will be blinded to all team members.
Accompaniment by clowns (Dr. Sonrisas from Funda-
cion Theodora) will depend on the clown presence/avail-
ability on the day of the intervention. An alphabetical
code will be assigned to patients assigned to clown ac-
companiment (A) or not (B).
Intervention
The study participants will be allocated to one of these
strategies:
– Group 1: Standard management consisting of
parental accompaniment during the preoperative
period, post-anaesthesia recovery area and up to
hospital discharge.
– Group 2: Standard management combined with
distraction and accompaniment by Dr. Sonrisas
during the preoperative period, post-anaesthesia
recovery area and up to hospital discharge. The
clown will be present with the children during the
post-anaesthesia period and up to discharge.
– Group 3: Standard management combined with
pharmacological intervention (oral hydroxyzine 2
mg/kg masked with 5 ml of juice, administered at
least 30 min prior to surgery).
– Group 4: Standard management combined with
accompaniment and distraction by Dr. Sonrisas and
hydroxyzine (as described in the previous groups).
All the patients will be filmed in order to later evaluate
the patient’s state of anxiety by the m-YPAS scale. Corti-
sol levels in saliva (using Salivette®) and blood will be
also analysed for all subjects.
Blinding
In order to hide clown accompaniment to the evaluator
of the m-YPAS, their appearance on the screen will be
avoided and the film will be silenced. Subjects in whose
film Dr. Sonrisas appears will be withdrawn from the
study. The evaluation of all films will be done by the
principal investigator.
Regarding hydroxyzine, the non-blinded nurse will ad-
minister 5 ml of juice to all subjects, mixed or not with
hydroxyzine, depending on the treatment arm assigned.
Treatment guideline
On the day of surgery, once the IC and, if applicable,
child agreements have been signed and the selection cri-
teria have been confirmed, the non-blinded nurse will
randomise the subjects. Juice, with or without hydroxy-
zine, will be administered to subjects at least 30 min
prior to the subject being transferred to the surgical
ward.
POA evaluation will be performed at the following
time-points:
– Time-point 0 (M0): Considered the baseline status
because it is the moment when the patient arrives to
the pre-surgical hospitalisation area prior to being in
contact with any method to reduce POA. At this
time-point, the investigators will record a film in
order to evaluate the patient’s baseline state of
anxiety by the m-YPAS.
– Time-point 1 (M1): During the stay in the pre-
surgical hospitalisation area, at least 30 min after
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receiving the assigned strategy. At this moment,
investigators will record a film to later evaluate the
subject’s preoperative state of anxiety by the m-
YPAS. The first Salivette® will be provided to the
patient for the collection and determination of
salivary cortisol. Salivette® will be collected before
leaving the pre-surgical hospitalisation area.
– Time-point 2 (M2): Moment when the patient is
transferred to the operating room up to the
entrance to the surgical ward and parental
separation. The investigators will record a film
during the transfer to the operating room and up to
the entrance to the surgical block to later evaluate a
subject’s preoperative anxiety by the m-YPAS scale.
At this time-point, the second Salivette® will be
collected when the patient is placed in the operating
room bed.
– Time-point 3 (M3): During the induction of
anaesthesia in the operating room: The investigators
will record a film during the induction of
anaesthesia to later evaluate subject’s preoperative
anxiety by the m-YPAS scale. At this time-point, the
anaesthesiologist will complete the Induction
Compliance Checklist and a blood sample (5 ml) will
be obtained for cortisol analysis.
– Stay in Post-Anaesthetic Care Unit (PACU): Upon
arrival at PACU and until recovery from anaesthesia,
the variables about recovery from anaesthesia, pain,
delirium, vital signs and postoperative analgesia will
be collected.
– Stay in General Ward: at the time of hospital
discharge, parents/legal guardians will complete
satisfaction survey as will children aged 5 years or
older. Healthcare professionals will complete this
survey at the end of the study.
Subjects will exit the study at hospital discharge.
Variables
Demographics
Age, sex, underlying pathology and the type of surgery
will be collected.
Outcome measures
– POA assessment: All subjects included in the study
will be filmed at four moments to later evaluate
their POA by the m-YPAS scale.
– Saliva and blood cortisol determination: Patients’
saliva will be collected by Salivette® device at time-
points M1 and M2. Likewise, a 5-ml blood sample
will be obtained at time-point M3 to determine
blood cortisol levels after the induction of
anaesthesia.
– Induction Compliance Checklist: It will be performed
by the anaesthesiologists in the operating room.
– Assessment of anaesthetic recovery with or without
presence of delirium using
PAEDS (PediatricAnesthesia Emergence Delirium
Scale) [21] and assessment of post-anaesthetic recov-
ery in PACU using Aldrete [22].
– Vital signs on arrival at PACU and every 30 min
until the transfer to general ward: heart rate and
respiratory rate.
– Pain Scales: Multidimensional pain scale for children
under 3 years old, face pain scale for children aged
4–7 years and Visual analog scale for children older
than 7 years old.
– Need of postoperative analgesia.
– Time to hospital discharge after leaving the
operating room, in minutes.
– Evaluation on perceived healthcare quality: to fulfil
this objective, a self-administered satisfaction survey
will be completed by patients and parents/legal
guardians after anaesthesia recovery and once
hospital discharge is indicated. Healthcare
professionals that usually attend children submitted
to Major Outpatient Paediatric Surgery and that are
involved in the study will complete the survey when
the study is finished. The survey used is elaborated
following the general criteria established by the
Madrid Health Service for the elaboration of citizen
satisfaction surveys [23]. Paediatric patients under 5
years old or older patients and parents/legal
guardians with cognitive impairment or difficulty in




Anxiety in children will be evaluated through comparing m-
YPAS score between the moment of induction of anaesthesia
and the presurgical moment prior to the entrance to the op-
erating room. The sample size calculated will allow detection
of a difference of means of 14.3 points at m-YPAS between
the group with parental accompaniment and hydroxyzine
(mean: 18; standard deviation (SD): 13.5 points) compared to
the group with parental accompaniment only (mean: 32.3;
SD: 24.2 points) [4, 24]. With a sample size of 47 subjects in
each group, we would have a power of 90%, with a level of
significance of 0.025, to detect these differences. The final
sample size would be 188 subjects (47 in each group).
Data analysis
The analysis will be performed by protocol and intention
to treat. The qualitative variables will be presented with
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their frequency distribution. The quantitative variables
will be summarised with their mean and SD. The quanti-
tative variables that show an asymmetric distribution will
be summarised with the median and interquartile range.
Comparison of the baseline characteristics of the four
study groups will be performed. The association between
qualitative variables will be evaluated by Pearson’s χ2 test
or by Fisher’s exact test. For quantitative variables,
means will be compared with Student’s t test for inde-
pendent groups or with nonparametric test for the quan-
titative variables if they do not fit a normal distribution.
For the main outcome (POA) and secondary quantita-
tive variables evaluated, a repeated measures analysis of
the variance (ANOVA) will be carried out. The Bonferroni
correction method will be used for multiple comparisons.
A comparison of means in each time-point and of the
interaction between the dependent variable of the analysis
(test score) and the study group (inter-subject factor) will
be assessed. If any baseline characteristics between groups
present clinically relevant differences, the model will be
adjusted by those variables. Qualitative variables will be
compared between groups using Pearson’s χ2 test. The
relative risk with 95% confidence intervals will be calcu-
lated. If any of the baseline characteristics between groups
presents statistically significant and/or clinically relevant
differences between the four study groups, odds ratio
(ORs) will be estimated using a logistic regression model.
For all tests, a significance level of 5% will be accepted.
The analysis of the data will be done by the statistical
package STATA 12.0.
Safety
Adverse events will be carefully monitored throughout
the study. All adverse events will be collected in the case
report form for each subject, regardless of the causal re-
lationship with study treatment. The investigator will
notify, within 24 h, all serious adverse events, serious ad-
verse reactions, unexpected adverse reactions, and ser-
ious and unexpected serious adverse reactions to the
sponsor. If any information is not available at the time
of notification, it will be completed within 7 calendar
days with a follow-up report. The sponsor will promptly
notify any information that could modify the benefit/risk
ratio of the investigational drug or that determines
changes in its administration schedule or in the per-
formance of the trial.
Ethical approvals
The study has been approved by the Clinical Research
Ethics Committee of the participating centre’s Hospital.
The confidentiality of subject data will be maintained at
all times in accordance with current legislation. All sub-
jects and/or parents/legal guardians are informed about
the study and will be asked for acceptance to participate
in it. This study will be carried out following international
ethical recommendations for conducting human research
and clinical trials contained in the latest revision of the
Declaration of Helsinki as well as those established in the
Good Clinical Practice Guidelines and current legislation.
All subjects will be supervised by qualified medical
personnel during their participation in the study.
Discussion
POA is observed amongst children during their stay in
the operative room with a prevalence of 83.3% [23]. Ad-
verse psychological and behavioural changes (decrease in
children’s self-esteem and emotional well-being, in-
creased anxiety, sleep disturbances and social isolation)
have been observed in a rate of 25% in children during
hospital stay and even at 1-year post-discharge [6]. A re-
cent systematic review also identified negative psycho-
logical sequelae in children [18].
The search for an ideal premedication drug to reduce
POA in children is ongoing. The drugs used as anxiolytics
are not exempt of side effects and the studies about this
issue are limited to dental procedures [14–16]. One study
[15] evaluated hydroxyzine at doses of 0.15mg/kg, yet the
dose proposed in our clinical trial is of 2mg/kg.
The role of clowns and hydroxyzine in the manage-
ment of anxiety is controversial as there are studies both
for and against them [18–20]. We have not found any
study that determines the additive effect on anxiolysis of
distracting techniques with clowns and pharmacological
treatment, as we propose in our case.
The proposed study has some limitations. The clowns
are not always at the hospital; therefore, assignment to this
intervention depends on whether they are present or not
on the day of surgery. In order to reduce this bias, the
healthcare professionals that plan the patient’s surgery will
not know when the clowns come to the hospital.
The main objective of this study is the evaluation of
POA. Studies that evaluate POA are difficult to perform
and interpret, mostly because of the difficulty in asses-
sing anxiety attributable to the surgical act. According to
some studies [3, 25], the moment with the maximum
rate of anxiety and fear associated with the entire surgi-
cal procedure is during anaesthetic induction. Therefore,
evaluating the child’s anxiety during anaesthetic induc-
tion is very useful to determine whether the strategies
used in the presurgical period have been effective in re-
ducing anxiety [26]. That is the reason why in the
present study, POA is evaluated in both moments. Most
studies on this topic use a presurgical anxiety rating
scale, the m-YPAS [23, 24, 26, 27].
Additionally, cortisol levels in blood and saliva correl-
ate with stress. Free fraction levels of cortisol in saliva
are a faithful reflection of its serum levels and it increase
in the same way when the patient is exposed to stressful
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situations that activate the axis. Therefore, in this study,
in order to establish the effect of the different strategies
to reduce POA, two different outcomes will be used, one
objective (cortisol levels) and one subjective (m-YPAS).
In the reviewed studies, satisfaction surveys about
healthcare quality are almost systematically carried out
by parents [5, 6]. In addition, in many of them, the per-
ception of the healthcare professionals involved is also
requested, observing a disparate impact of the different
POA management strategies depending on the profes-
sional questioned [9]. The present study will consider
not only parents and professional opinion, but also chil-
dren’s perception of the healthcare quality of the presur-
gical interventions to reduce POA.
If the hypothesis of this study is confirmed, the com-
bination of clowns and hydroxyzine may be considered
the most effective and safety option for the treatment of
POA in children.
Trial status
Subject recruitment started in 12th January 2018 and is
ongoing, recruitment will be completed in 30th Decem-
ber 2019. Protocol version: 7 (1st April 2019).
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13063-019-3906-2.
Additional file 1. SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents.
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